ALTME:EPA
TME Pharma NV
€0.11
0.00%
(0.00) 1D
Oct 22, 5:35:12 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALTME...
Mkt. cap
10.94M
Avg. vol.
1.50M
Volume
0.00
52-wk high
€0.17
52-wk low
€0.05
EPS
-€0.03
No. of employees
0
Mkt. cap
10.94M
Avg. vol.
1.50M
Volume
0.00
52-wk high
€0.17
52-wk low
€0.05
EPS
-€0.03
No. of employees
0
News stories
From web sources and news partners
CryptoTicker
·
22 minutes ago
Bitcoin price $81,568 after $431m liquidations
Investing.com
·
3 minutes ago
Nasdaq, Treasury Yields and US Dollar Face a Major AI Sentiment Test
Trefis
·
46 minutes ago
The 52-Week-Low List: 3 S&P 500 Names On Thursday
Profile
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
About TME Pharma NV